Cantitate/Preț
Produs

Receptor Tyrosine Kinases: Advances in Cancer Research, cartea 147

Rakesh Kumar, Paul B. Fisher
en Limba Engleză Hardback – 25 iun 2020
Receptor Tyrosine Kinases, Volume 147 in the Advances in Cancer Research series, provides invaluable information on the exciting and fast-moving field of cancer research in the area of Receptor Tyrosine Kinases (RTKs) in the context of major basic science and translational advances, their importance in the development of a large number of anti-cancer drugs over the decades, and a peek into postulated advances in the coming decades for a number of RTK. Chapters in this new release are contributed by a group of International leading scientists who have a rich history in this field.


  • Provides the latest information on core advances in receptor tyrosine kinases in cancer research
  • Offers outstanding and original reviews on a range of cancer research topics by leading authorities in the field
  • Serves as an indispensable reference for faculty, researchers and students alike
Citește tot Restrânge

Din seria Advances in Cancer Research

Preț: 72874 lei

Preț vechi: 113416 lei
-36% Nou

Puncte Express: 1093

Preț estimativ în valută:
13948 14537$ 11611£

Carte tipărită la comandă

Livrare economică 30 decembrie 24 - 13 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780128201428
ISBN-10: 0128201428
Pagini: 444
Dimensiuni: 152 x 229 mm
Greutate: 0.76 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Cancer Research


Public țintă

Researchers and students in the basic and clinical sciences of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology, and molecular biology

Cuprins

Contributions from:Yosef Yarden, Ph.D., Weizmann Institute of Science, ISRAELRakesh Kumar, Ph.D., Rajiv Gandhi Center for Biotechnology, INDIAPaul Fisher, M.D., Ph.D., Virginia Commonwealth University, School of Medicine, USAMark Moasser, M.D., University of California San Francisco, USA William J. Muller, Ph.D., McGill University, CANADA Ravi Salgia, M.D., Ph.D., City of Hope's Comprehensive Cancer Center, USARenata Pasqualini, Ph.D., Rutgers NJ School of Medicine, USAFernanda Staquicini, Ph.D., Rutgers NJ School of Medicine, USAM. Radhakrishna Pillai, Ph.D., Rajiv Gandhi Center for Biotechnology, INDIAMien-Chie Hung, Ph.D., China Medical University, TAIWANE. Prem Reddy, Ph.D., Mount Sanai School of Medicine, USADoug Yee, M.D., Masonic Cancer Center University of Minnesota, USANandini Verma, Ph.D., Advanced Centre for Treatment, Research and Education in Cancer, Mumbai, INDIA Masakazu Toi, M.D., Ph.D., Kyoto University School of Medicine, JAPANLouis Chow, M.D., UNIMED Medical Institute, Hong Kong, CHINALuis Marques da Costa, M.D., Ph.D., University of Lisbon School of Medicine, PORTUGAL